CERCAM is a prognostic biomarker associated with immune infiltration of macrophage M2 polarization in head and neck squamous carcinoma

被引：0
作者：
Ying Yang
Cong Yan
Xiao-Jian Chen
机构：
[1] General Hospital of the Central Theater Command,Department of Stomatology
[2] China Medical University,Department of Oral Maxillofacial
[3] Liaoning Provincial Key Laboratory of Oral Diseases,Head and Neck Surgery, School of Stomatology
来源：
BMC Oral Health | / 23卷
关键词：
CERCAM; HNSCC; Prognosis; Macrophages; Immune infiltration;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 210 条
  • [1] Siegel RL(2022)Cancer statistics, 2022 CA Cancer J Clin 72 7-33
  • [2] Miller KD(2010)Recent advances in surgery for head and neck cancer Curr Opin Oncol 22 186-193
  • [3] Fuchs HE(2019)Modern radiotherapy for head and neck cancer Semin Oncol 46 233-245
  • [4] Jemal A(2020)Palliative chemotherapy in head and neck cancer: balancing between beneficial and adverse effects Expert Rev Anticancer Ther 20 17-29
  • [5] de Bree R(2019)Immunotherapy for head and neck cancer: recent advances and future directions Oral Oncol 99 104460-1561
  • [6] Leemans CR(2021)Epithelial-to-mesenchymal transition in oral squamous cell carcinoma: challenges and opportunities Int J Cancer 148 1548-112
  • [7] Alterio D(2020)Biomarkers for immunotherapy response in head and neck cancer Cancer Treat Rev 84 101977-573
  • [8] Marvaso G(2018)Serum, plasma and saliva biomarkers for head and neck cancer Expert Rev Mol Diagn 18 85-640
  • [9] Ferrari A(2021)Genetics and molecular biology of head and neck cancer Biomolecules. 11 1293-73
  • [10] Volpe S(2007)Cell-matrix adhesion J Cell Physiol 213 565-157
12345678910